3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
9
Other hematologic neoplasm
7
Myeloid
4
Plasma cell
2
Sarcoma
1
Head & Neck
1
Genitourinary
1
Endocrine
1
CNS
1
Conditions
Sarcoma
7
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Thyroid Neoplasms
3
Thyroid Cancer, Papillary
3
Salivary Gland Neoplasms
3
Head and Neck Neoplasms
3
Gastrointestinal Stromal Tumors
3
Central Nervous System Neoplasms
3
Breast Neoplasms
3
Brain Neoplasms
3
Thyroid Diseases
2
Thoracic Neoplasms
2
Respiratory Tract Neoplasms
2
Respiratory Tract Diseases
2
Ovarian Neoplasms
2
Neuroendocrine Tumors
2
Neuroblastoma
2
Neoplasms by Site
2
Melanoma
2
Medulloblastoma
2
Lung Neoplasms
2
Lung Diseases
2
Glioma
2
Endocrine System Diseases
2
Endocrine Gland Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Bronchogenic
2
Bronchial Neoplasms
2
Interventions
entrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Recurrence
×
Sarcoma
×
Clear all
NCT02650401
2026-03-25
STARTRK-NG
Hoffmann-La Roche
Phase 1/2
Active not recruiting
69 enrolled
1 FDA